Literature DB >> 31385389

Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations.

Fanny W S Ko1, Ka Pang Chan1, Jenny Ngai1, So-Shan Ng1, Wing Ho Yip1, April Ip1, Tat-On Chan1, David S C Hui1.   

Abstract

BACKGROUND AND
OBJECTIVE: Airway inflammation accompanying exacerbations varies among individuals with some having neutrophilic, while others showing eosinophilic inflammation. This study assessed the cut-off values of blood eosinophil count for identifying subjects with longer hospital length of stay (LOS) with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
METHODS: Patients were recruited at presentation to the hospital with an AECOPD. Complete blood picture with differential count was taken on admission. Patients were treated with a standard course of systemic corticosteroid and antibiotic and evaluated at 8 weeks post-exacerbation for lung function measurement and 6-min walk. They were followed up in 1 year for any readmissions or mortality. Cut-off values of eosinophils for assessment of longer LOS were calculated using receiver operating characteristic (ROC) curve analysis.
RESULTS: A total of 346 patients with admission eosinophil count were included in the analysis (333 (96.2%) were males; mean ± SD age: 74.9 ± 7.8 years; mean forced expiratory volume in 1 s (FEV1 ): 43.4 ± 16.3% predicted). The median (interquartile range (IQR)) of the absolute peripheral eosinophil count, percent eosinophil count and LOS were 0.11 (0.25) × 109 /L, 1 (3) % and 5 (7) days, respectively. Using the median LOS of ≥5 days as the cut-off, ROC analysis of the cut-off value of eosinophil count associated with longer LOS was at <2% (area under the curve (AUC): 0.666, P < 0.001) while absolute eosinophil count was at <0.144 × 109 /L (AUC: 0.645, P < 0.001). These eosinophil cut-off values could predict longer LOS independent of age, lung function and previous hospital admissions, but had no association with readmissions for AECOPD and mortality at 12 months.
CONCLUSION: An eosinophil value of <0.144 × 109 /L on admission or <2% was associated with longer hospital LOS for AECOPD.
© 2019 Asian Pacific Society of Respirology.

Entities:  

Keywords:  airway inflammation; chronic obstructive pulmonary disease; eosinophils; exacerbations

Mesh:

Year:  2019        PMID: 31385389     DOI: 10.1111/resp.13660

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  15 in total

1.  Long-term oxygen treatment need is less frequent in eosinophilic COPD patients.

Authors:  Nilüfer Aylin Acet-Öztürk; Asli G Dilektasli; Özge Aydın-Güçlü; Ezgi Demirdöğen; Funda Coşkun; Ahmet Ursavaş; Mehmet Karadağ; Esra Uzaslan
Journal:  Clin Respir J       Date:  2021-10-26       Impact factor: 1.761

2.  Peripheral Blood Eosinophil as a Biomarker in Outcomes of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Hong-Xia Wu; Kai-Quan Zhuo; De-Yun Cheng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-12-24

3.  The lower the eosinophils, the stronger the inflammatory response? The relationship of different levels of eosinophils with the degree of inflammation in acute exacerbation chronic obstructive pulmonary disease (AECOPD).

Authors:  Mei-Yu Lv; Li-Xia Qiang; Zhi-Heng Li; Shou-De Jin
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

4.  Association Between Blood Eosinophils and Mortality in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study.

Authors:  Jia Yang; Junchao Yang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-02-11

Review 5.  Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease.

Authors:  Pradeesh Sivapalan; András Bikov; Jens-Ulrik Jensen
Journal:  Diagnostics (Basel)       Date:  2021-02-03

6.  Factors associated with inpatient length of stay among hospitalised patients with chronic obstructive pulmonary disease, China, 2016-2017: a retrospective study.

Authors:  Ting Yang; Jianjun Jiao; Fen Dong; Ke Huang; Xiaoxia Ren; Shiwei Qumu; Hongtao Niu; Yanyan Wang; Yong Li; Minya Lu; Xinshan Lin; Chen Wang
Journal:  BMJ Open       Date:  2021-02-05       Impact factor: 2.692

7.  The role of elevated red blood cell distribution width in the prognosis of AECOPD patients: A retrospective study.

Authors:  Mengpei Zhu; Hongxing Peng; Lei Wan; Shuling Zhang; Yulan Zeng
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

8.  Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses.

Authors:  Balázs Csoma; András Bikov; Ferenc Tóth; György Losonczy; Veronika Müller; Zsófia Lázár
Journal:  ERJ Open Res       Date:  2021-02-08

9.  Blood Eosinophils and Clinical Outcomes in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Propensity Score Matching Analysis of Real-World Data in China.

Authors:  Yanan Cui; Zijie Zhan; Zihang Zeng; Ke Huang; Chen Liang; Xihua Mao; Yaowen Zhang; Xiaoxia Ren; Ting Yang; Yan Chen
Journal:  Front Med (Lausanne)       Date:  2021-06-09

10.  High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis.

Authors:  Timm Greulich; Julia Tüffers; Sina Mager; Anna Eder; Michael Maxheim; Peter Alter; Bernd Schmeck; Claus F Vogelmeier
Journal:  Respir Res       Date:  2020-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.